Home›Stock Screener›Artemis Medicare Services

Artemis Medicare Services Share Price Today | Stock Price & Artemis Medicare Services Share Screener

ARTEMISMED Hospitals
Live Share Price NSE
₹324.10
▼ -12.30 (-3.66%)
2026-10-05 00:00:00
Live Share Price BSE
₹323.80
▼ -12.65 (-3.76%)
2026-10-05 00:00:00

As of October 5, 2026, the live Artemis Medicare Services share price (NSE: ARTEMISMED) is ₹324.10 on NSE and ₹323.80 on BSE, down 3.66% from the previous close, with shares trading between ₹322.35 and ₹341.85 in today's trading session, and a 52-week range of ₹205.51–₹366.60. Check ARTEMISMED annual price range for the annual price range and momentum. Use the Artemis Medicare Services stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Artemis Medicare Services opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹287 and net income of ₹30, with EBITDA of ₹59, an operating margin of 18.0% and a profit margin of 10.5%.

Artemis Medicare Services Market Cap ₹5,803.51 Cr.
ARTEMISMED P/E Ratio (TTM) 50.69
Artemis Medicare Services P/B Ratio 6.67
EPS (TTM) ₹6.56
Dividend Yield 0.12%
Debt to Equity 0.34
ARTEMISMED 52 Week High ₹366.60
Artemis Medicare Services 52 Week Low ₹205.51
Operating Margin 18.00%
Profit Margin 10.45%
ARTEMISMED Revenue (TTM) ₹287.00
EBITDA ₹59.00
Net Income ₹30.00
Total Assets ₹1,429.00
Total Equity ₹941.00

Artemis Medicare Services Share Price Chart

Track the current stock price of Artemis Medicare Services with an interactive chart. Analyse ARTEMISMED share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Artemis Medicare Services stock quote in one place.

The quote of ₹324.10 sits between the 52-week low of ₹205.51 and the 52-week high of ₹366.60, and the latest session moved -3.66% from the previous close.

Artemis Medicare Services Company Profile - Fundamental Screener

Screen Artemis Medicare Services company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for ARTEMISMED shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare Services sector and the Hospitals industry, and it trades under ISIN INE025R01021.

Company Details

Classification

Sector Healthcare Services
Industry Hospitals
Sub-Sector Hospitals
Segment E

Identifiers and Leadership

ISIN INE025R01021

Artemis Medicare Services Balance Sheet Screener

Screen ARTEMISMED balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹1,429, up from ₹1,357 in 2025.

Latest statistics put total assets at ₹1,429 and shareholder funds at ₹941, with a leverage ratio of 0.34.

Item 2026 2025 2024 2023 2022 2021 2020 2019

Assets

Total Assets 1,429 1,357 972 905 710 600 586 554
Current Assets 367 535 180 170 127 110 118 113
Fixed Assets 804 745 719 605 489 383 393 381

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0
Current Liabilities 277 298 332 292 210 160 115 84
Non-Current Liabilities 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 941 844 455 408 361 322 314 293
Share Capital 16 14 14 13 13 13 13 13
Reserves & Surplus 919 503 435 390 346 307 300 280

Artemis Medicare Services Income Statement Screener - Profit & Revenue Analysis

Screen Artemis Medicare Services income statement and profit fundamentals. Analyze ARTEMISMED quarterly results. Artemis Medicare Services reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Mar, revenue was ₹287 and net profit was ₹30, equal to earnings per unit of ₹1.90, at an operating margin of 18%.

In that period expenses were ₹228, interest cost ₹6 and tax ₹10. The next period listed, 2026-Jun, shows revenue of ₹293 and net profit of ₹31.

Item 2026-Mar 2026-Jun 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept 2024-Dec 2023-Mar 2023-Jun 2023-Sept 2023-Dec 2022-Mar

Revenue and Expenses

Revenue 287 293 252 262 282 280 227 228 249 241 198 211 227 221 151
Expenses 228 231 204 214 224 231 187 187 199 195 170 182 191 186 132

Operating Costs and Margins

EBITDA 59 62 48 48 58 49 40 41 50 46 28 29 37 34 18
Operating Profit % 18.00% 20.00% 15.00% 16.00% 18.00% 15.00% 17.00% 16.00% 18.00% 16.00% 13.00% 13.00% 15.00% 15.00% 11.00%
Depreciation 13 13 12 11 12 12 11 11 11 11 9 9 10 10 6
Interest 6 7 8 7 7 7 9 8 8 8 5 7 8 8 4

Profit and Earnings

Profit Before Tax 40 43 29 30 39 30 20 22 31 27 14 13 19 16 8
Tax 10 11 6 9 9 8 6 5 8 6 3 3 5 5 -5
Net Profit 30 31 23 21 30 22 14 17 22 21 11 10 14 12 13
EPS 1.90 1.98 1.47 1.35 1.90 1.41 1.04 1.14 1.42 1.32 0.79 0.72 1.00 0.85 1.00

Artemis Medicare Services Cash Flow Screener - Liquidity Fundamentals

Screen ARTEMISMED cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹132, and net cash flow was an outflow of ₹8.

Over the same period, investing activities used ₹90 and financing activities used ₹50.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March

Cash from Operations and Investing

Operating Activities 132 156 109 127 60 27 56 41
Investing Activities -90 -393 -88 -158 -107 -37 -26 -50

Financing and Net Cash

Financing Activities -50 265 -29 38 44 18 -27 14
Net Cash Flow -8 27 -8 7 -4 8 2 5

Artemis Medicare Services Shareholding Pattern Screener

See Artemis Medicare Services shareholding pattern with promoter, FII, and DII holdings. Check Artemis Medicare Services promoter holding and ownership changes for ARTEMISMED on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 58.39%, foreign institutions 12.19%, domestic institutions 2.89% and the public 12.36%, spread across 32,044 shareholders.

The shareholder count was 32,044 in 2026-Mar, compared with 36,335 in 2026-Jun.

Item 2026-Mar 2026-Jun 2025-Mar 2025-Jun 2025-Sept 2025-Nov 2025-Dec 2024-Mar

Promoter Holding

Promoter Holding 58.39% 58.39% 67.17% 66.53% 66.53% 58.43% 58.39% 68.03%

Institutional Investors

FII Holding 12.19% 12.29% 0.31% 0.24% 0.37% 12.48% 12.47% 0.10%
DII Holding 2.89% 2.40% 5.04% 4.76% 4.27% 3.35% 2.91% 2.61%

Government, Public and Others

Govt Holding 6.16% 6.16% 7.09% 7.02% 7.02% 6.16% 6.16% 7.18%
Public Holding 12.36% 12.79% 12.86% 12.93% 13.44% 11.65% 12.12% 14.74%
Other Holding 8.01% 7.97% 7.53% 8.52% 8.37% 7.93% 7.96% 7.34%
Shareholder Count 32,044 36,335 28,397 31,614 33,559 31,884 31,602 19,993

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Artemis Medicare Services. Artemis Medicare Services dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹0.45 per unit for 2026-March, a yield of 0.13%, compared with ₹0.45 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹0.45, ₹0.45 and ₹0.45 per unit.

Period Dividend Per Share Dividend Yield
2026-March ₹0.45 0.13%
2025-March ₹0.45 0.22%
2024-March ₹0.45 0.16%
2023-March ₹0.45 0.26%
2022-March ₹0.00 0.00%
2021-March ₹0.00 0.00%
2020-March ₹0.00 0.00%
2019-March ₹0.00 0.00%
2018-March ₹0.00 0.00%
2017-March ₹0.00 0.00%

Artemis Medicare Services Stock Index Membership - Nifty & Sensex

See which indices include Artemis Medicare Services stock. Check ARTEMISMED index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

The company is listed in 2 indices, including BSE INDEX BSE HC.

Among the benchmarks tracked are BSE INDEX BSE HC, BSE INDEX SMLCAP.

Complete Index List

BSE INDEX BSE HC
BSE INDEX SMLCAP

Artemis Medicare Services Market Events Screener - Corporate Actions

Get Artemis Medicare Services corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Artemis Medicare Services stock events that may affect ARTEMISMED share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated August 3, 2026, with a record date of August 3, 2026.

It is followed by Annual General Meeting dated July 31, 2026 and Dividend dated July 10, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-08-03 2026-08-03 Quarterly Result Announcement NA 7.68%
2026-07-31 2026-07-31 Annual General Meeting NA 17.28%
2026-07-10 2026-07-10 Dividend ₹ 0.45 /share 0.71%
2026-05-08 2026-05-08 Quarterly Result Announcement NA 6.53%
2026-02-02 2026-02-02 Quarterly Result Announcement NA 5.62%
2025-11-11 2025-11-11 Quarterly Result Announcement NA 0.02%
2025-08-05 2025-08-05 Quarterly Result Announcement NA 6.20%
2025-07-30 2025-07-30 Annual General Meeting NA -3.97%
2025-07-11 2025-07-11 Dividend ₹ 0.45 /share 5.08%
2025-05-12 2025-05-12 Quarterly Result Announcement NA -8.22%
2025-02-05 2025-02-05 Quarterly Result Announcement NA 2.93%
2024-11-14 2024-11-14 Quarterly Result Announcement NA -1.84%
2024-07-24 2024-07-24 Annual General Meeting NA 23.92%
2024-07-05 2024-07-05 Dividend ₹ 0.45 /share -4.82%
2024-05-03 2024-05-03 Extraordinary General Meeting NA -2.08%

Artemis Medicare Services Competitors Screener - Peer Stocks Comparison

Screen ARTEMISMED competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare Services sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Apollo Hospitals 124,503 58.67 25,420 15.58% 2,003 43.13
Max Healthcare Institute 95,582 66.86 8,536 18.82% 1,442 36.74
Aster DM Quality Care 63,976 179.76 4,769 11.25% 427 36.84
Fortis Healthcare 62,058 58.65 9,179 16.93% 1,064 25.57
Global Health 38,047 69.81 4,509 19.56% 554 44.47
Narayana Hrudayalaya 36,579 45.50 7,996 43.43% 811 38.14
Krishna Institute of Medical Sciences 32,336 165.49 3,931 28.16% 242 45.36
Dr. Agarwal's Health Care 15,699 86.39 2,125 20.92% 168 44.18
Rainbow Childrens Medicare 13,891 48.05 1,747 11.49% 282 31.72
Park Medi World 11,898 40.25 1,711 19.99% 274 41.32

Artemis Medicare Services Company Announcements - News & Reports Screener

Screen ARTEMISMED latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated September 22, 2026.

The next most recent announcements are dated September 8, 2026 and August 27, 2026.

Date Update Actions
2026-09-22 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-09-08 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-08-27 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-08-10 Announcement under Regulation 30 (LODR)-Earnings Call Transcript -
2026-08-10 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-08-04 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome -
2026-08-04 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-03 Announcement under Regulation 30 (LODR)-Monitoring Agency Report -
2026-08-03 Announcement under Regulation 30 (LODR)-Press Release / Media Release -
2026-08-03 Announcement under Regulation 30 (LODR)-Investor Presentation -
2026-08-03 Announcement Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 -
2026-08-03 Un-Audited Financial Results (Standalone And Consolidated) Of The Company For The Quarter Ended June 30 2026 -
2026-08-03 Board Meeting Outcome for Board Meeting Held On August 3 2026 -
2026-08-03 Announcement under Regulation 30 (LODR)-Change in Directorate -
2026-07-31 Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s -
2026-07-31 Announcement under Regulation 30 (LODR)-Change in Directorate -
2026-07-31 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-07-31 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-07-29 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-07-29 Board Meeting Intimation for Consideration Of Un-Audited Financial Results -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹324.10, within a 52-week range of ₹205.51 to ₹366.60. The P/E ratio is 50.69 and the P/B ratio is 6.67, with earnings per unit of ₹6.56. Market capitalisation stands at ₹5,803.51 Cr and the dividend yield is 0.12%. The company operates in the Healthcare Services sector, in the Hospitals industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on September 29, 2026. This page covers 8 balance sheet periods, 15 income statement periods, 8 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.